Fouad Mikhail: Mechanical Thrombectomy and Anticoagulation in Intermediate-Risk Pulmonary Embolism
Fouad Mikhail, Sub-speciality Coordinator at NEGIDA Corporation, shared on LinkedIn about a recent article he and his colleagues co-authored, published in Catheterization and Cardiovascular Interventions, adding:
“Honored to share that our original research has been accepted for publication in Catheterization and Cardiovascular Interventions (CCI) Impact Factor: 2.1 (SJR: 0.964 -Q1 in Cardiology and Cardiovascular Medicine).
In this work, we took a granular, risk-stratified approach to a clinically urgent question:
- In intermediate-risk PE, does mechanical thrombectomy offer a survival advantage over anticoagulation alone?
While MT was associated with lower 1-year mortality across both subgroups, the net clinical benefit differs sharply by risk profile—which may help refine patient selection for this rapidly adopted procedure.
- Large, real‑world cohort from a federated network of 165+ healthcare organizations
- Risk‑stratified design (low‑intermediate vs. high‑intermediate PE)
The paper is now published.
Special thanks to my dearest mentor that I have always learnt from .. Dr. Ahmed Abdelmaksoud and for my all time teammates Dr. Ali Dway and Dr. Abdulrahman El helbawy as well as our senior authors and all co‑authors for their invaluable contributions.”
Title: Mechanical Thrombectomy Versus Anticoagulation in Intermediate-Risk Pulmonary Embolism: A Risk-Stratified, Propensity Score–Matched Analysis
Authors: Fouad Hanna, Ahmed Abdelmaksoud, Ali Dway, Abdelrahman El-Helbawy, David C. Kaelber, Habib Rehman Khan, Noha Hammad, Amr Mohsen, Mina Basta
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 31, 2026, 16:39Shariq Shamim: Are We Going to Start DOAC post TAVI not DAPT?
-
Aug 31, 2026, 16:30Bartosz Hudzik: 5th Universal MI Definition Moves Closer to Biology in Women
-
Aug 31, 2026, 16:13Seema Dawood: Nucleated Red Blood Cells – What They Tell Us on a Peripheral Smear
-
Aug 31, 2026, 16:02Antonio Sorropago: Major Updates in Structural Heart Interventions
-
Aug 31, 2026, 15:44Andrea Boccatonda: Special Issue on Pulmonary Embolism and Venous Thromboembolism
-
Aug 31, 2026, 15:41Adrien Jossart: Acute Thrombotic Storm Following Single Heparin Bolus
-
Aug 31, 2026, 15:36Bernhard Gerber: Myocardial Platelet Activation Linked to Microvascular Obstruction After STEMI
-
Aug 31, 2026, 15:34Higher Fibrinogen γ′ Linked to Increased Risk of Recurrent Arterial Thrombosis – Journal of Thrombosis and Haemostasis
-
Aug 31, 2026, 15:21Ney Carter Borges: Anticoagulation Versus Antiplatelet Therapy After TAVI ESC 26